BACKGROUND/AIMS: The purpose of this study was to assess liver-type fatty acid-binding protein (L-FABP) expression and its association with clinicopathological features in hepatocellular carcinoma (HCC). METHODOLOGY: L-FABP mRNA expression in 57 samples of HCC and corresponding adjacent liver tissue and 8 normal liver tissue samples were examined by real-time reverse transcriptase (RT)–PCR analyses. Tissue microarray technique and immunohistochemistry (IHC) were used to detect the expression of L-FABP in 163 HCCs. The association between L-FABP expression and the clinicopathological factors and prognosis was analyzed. RESULTS: The average expression of L-FABP mRNA was 0.233 in the HCC tissues, 1.407 in the peri-carcinoma tissues, and 1.0 in the normal liver tissues. IHC analysis showed that there were 47% (76/163) HCCs exhibited weak or even no immunoreactivity of L-FABP. The L-FABP expression in HCC showed significant associations with preoperative levels of AFP (p=0.039), tumor size (p=0.026), histological grade (p=0.000), differential degree (p=0.000), vascular invasion (p=0.016), capsular invasion (p=0.029) and recurrence (p=0.004). Patients with L-FABP high-expression showed better prognosis than patients with L-FABP low-expression (p=0.008). CONCLUSIONS: L-FABP was downregulated in HCC and could be served as a promising prognostic marker for HCC patients.
BACKGROUND/AIMS: The purpose of this study was to assess liver-type fatty acid-binding protein (L-FABP) expression and its association with clinicopathological features in hepatocellular carcinoma (HCC). METHODOLOGY:L-FABP mRNA expression in 57 samples of HCC and corresponding adjacent liver tissue and 8 normal liver tissue samples were examined by real-time reverse transcriptase (RT)–PCR analyses. Tissue microarray technique and immunohistochemistry (IHC) were used to detect the expression of L-FABP in 163 HCCs. The association between L-FABP expression and the clinicopathological factors and prognosis was analyzed. RESULTS: The average expression of L-FABP mRNA was 0.233 in the HCC tissues, 1.407 in the peri-carcinoma tissues, and 1.0 in the normal liver tissues. IHC analysis showed that there were 47% (76/163) HCCs exhibited weak or even no immunoreactivity of L-FABP. The L-FABP expression in HCC showed significant associations with preoperative levels of AFP (p=0.039), tumor size (p=0.026), histological grade (p=0.000), differential degree (p=0.000), vascular invasion (p=0.016), capsular invasion (p=0.029) and recurrence (p=0.004). Patients with L-FABP high-expression showed better prognosis than patients with L-FABP low-expression (p=0.008). CONCLUSIONS:L-FABP was downregulated in HCC and could be served as a promising prognostic marker for HCC patients.
Authors: Rondell P Graham; Luigi M Terracciano; Alexander Meves; Patrick M Vanderboom; Surendra Dasari; Matthew M Yeh; Michael S Torbenson; Michael W Cruise Journal: Mod Pathol Date: 2016-03-25 Impact factor: 7.842
Authors: Brian McMahon; Joan Block; Timothy Block; Chari Cohen; Alison A Evans; Anu Hosangadi; W Thomas London; Morris Sherman Journal: J Natl Cancer Inst Date: 2015-11-30 Impact factor: 13.506
Authors: Christina Nadolny; Xinmu Zhang; Qiwen Chen; Syed F Hashmi; Winifer Ali; Christopher Hemme; Nagib Ahsan; Yuan Chen; Ruitang Deng Journal: Am J Cancer Res Date: 2021-10-15 Impact factor: 6.166
Authors: David Dum; Ana Ocokoljic; Maximilian Lennartz; Claudia Hube-Magg; Viktor Reiswich; Doris Höflmayer; Frank Jacobsen; Christian Bernreuther; Patrick Lebok; Guido Sauter; Andreas M Luebke; Eike Burandt; Andreas H Marx; Ronald Simon; Till S Clauditz; Sarah Minner; Anne Menz; Franziska Büscheck; Natalia Gorbokon; Stefan Steurer; Niclas C Blessin; Till Krech Journal: Virchows Arch Date: 2022-08-11 Impact factor: 4.535
Authors: Beata Ostasiewicz; Paweł Ostasiewicz; Kamila Duś-Szachniewicz; Katarzyna Ostasiewicz; Piotr Ziółkowski Journal: Mol Med Rep Date: 2016-04-27 Impact factor: 2.952